Seth Shay Martin, MD, MHS, FACC

Seth Martin

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Sanofi-Regeneron(MODEST), Amgen Inc.(MODEST), AstraZeneca Pharmaceuticals(SIGNIFICANT), Kaneka(SIGNIFICANT), Novartis(SIGNIFICANT), Novo Nordisk(MODEST), 89 bio(MODEST), Dalcor(MODEST) OFFICER, DIRECTOR ETC: Corrie Health(NONE) RESEARCH/RESEARCH GRANTS: Apple(SIGNIFICANT), iHealth(SIGNIFICANT)

View Full Disclosure